Immunoglobulin class switching is crucial for the generation of antibody diversity in humoral immunity and, when deregulated, also has severe pathological consequences. How the magnitude of immunoglobulin isotype switching is controlled is still poorly understood. Here we identify the kinase TBK1 as a pivotal negative regulator of class switching to the immunoglobulin A (IgA) isotype. B cell-specific ablation of TBK1 in mice resulted in uncontrolled production of IgA and the development of nephropathylike disease signs. TBK1 negatively regulated IgA class switching by attenuating noncanonical signaling via the transcription factor NF-kB, an action that involved TBK1-mediated phosphorylation and subsequent degradation of the NF-kB-inducing kinase NIK. Our findings establish TBK1 as a pivotal negative regulator of the noncanonical NF-kB pathway and identify a unique mechanism that controls IgA production.
B cells serve as the main participants in the humoral immune responses to infection but are also responsible for various autoimmune disorders. After being activated by an antigen, mature B cells proliferate and undergo a series of differentiation events, including immunoglobulin class switching, to acquire the ability to produce antibodies of various isotypes with specialized effector functions. In particular, immunoglobulin A (IgA) has an important role in mediating mucosal immunity, and deficiency in IgA is a commonly seen primary immunodeficiency in humans [1] [2] [3] . Conversely, IgA production is tightly controlled, as its deregulation contributes to the pathogenesis of severe diseases, such as IgA nephropathy, characterized by high serum concentrations of IgA and antibody deposition in kidney glomeruli as well as symptoms of kidney dysfunction [4] [5] [6] . The induction of class switching to IgA involves various signals, most notably stimulation via transforming growth factor-β (TGF-β) and costimulatory signals triggered by the ligand for the costimulatory molecule CD40 (CD40L) or its related tumor-necrosis factor (TNF) family members BAFF and APRIL [7] [8] [9] [10] [11] [12] .
A common signaling function of members of the TNF receptor family is activation of the NF-κB proteins, a family of transcription factors with diverse functions in the immune system 13, 14 . Activation of NF-κB is mediated by canonical and noncanonical pathways [13] [14] [15] . Although the canonical pathway has been studied extensively, much remains to be investigated about the regulation and functions of the noncanonical pathway. The latter pathway depends on the NF-κBinducing kinase NIK and its downstream kinase IKKα, which induces the processing of p100, an NF-κB precursor protein that also functions as a cytoplasmic inhibitor of NF-κB. The processing of p100 not only generates the mature NF-κB subunit p52 but also leads to translocation of the sequestered members of the NF-κB family to the nucleus 15 . Although p52-RelB is the main NF-κB complex induced by the noncanonical NF-κB pathway, it may also contribute to the activation of other members of the NF-κB family in B cells 16 . Consistent with that, mice that express an inactive NIK mutant or a processing-deficient p100 mutant (Lym1) have much more severe immune defects than do p52-or RelB-deficient mice [16] [17] [18] [19] [20] .
Unlike the canonical NF-κB pathway, which responds to diverse stimuli, the noncanonical NF-κB pathway selectively responds to a small subset of members of the TNF receptor family, including CD40 and BAFFR, whose ligands are CD40L and BAFF, respectively 21 . A related member of this family, TACI, recognizes both BAFF and APRIL and also induces the noncanonical NF-κB pathway, albeit less efficiently than BAFFR does [21] [22] [23] [24] . Although the role of noncanonical NF-κB pathway in class switching to IgA has not been definitively demonstrated, accumulating evidence suggests this possibility. Mice with mutation of Map3k14 (which encodes NIK) or mice that express the processing-defective Lym1 p100 mutant have considerable defects in IgA production 16, 17 . Bone marrow adoptive-transfer studies have further indicated a function for NIK in hematopoietic cells that regulates the systemic production of IgA 25 . Moreover, overexpression of the noncanonical NF-κB inducer BAFF in B cells causes IgA hyperproduction and IgA nephropathy 5, 6 . However, despite such functional connections, how the signal-induced noncanonical activation of NF-κB and class switching to IgA are controlled remains unknown.
The kinase TBK1, as well as its homolog IKKε (IKKi), are known as signaling factors of the innate immune system that mediate the induction of type I interferons in response to stimulation via Toll-like receptors and viral infection [26] [27] [28] [29] [30] . However, because of the embryonic 1 1 0 2 VOLUME 13 NUMBER 11 NOVEMBER 2012 nature immunology A r t i c l e s death of mice with global TBK1 deficiency 31 , the in vivo biological functions of TBK1 have remained largely unknown. Here we generated mice with conditional deficiency in TBK1 in B cells (called 'Tbk1-BKO mice' here). Our studies led to the discovery of an unexpected and notable function for TBK1 in the control of class switching to IgA. TBK1 inhibited such class switching by specifically opposing the signaling function of members of the TNF family and that in turn involved attenuation of noncanonical activation of NF-κB. TBK1 mediated the phosphorylation and degradation of NIK, thereby preventing aberrant accumulation of this central signaling component of the noncanonical NF-κB pathway. Our findings establish TBK1 as a critical regulator of IgA class switching and suggest a pivotal role for TBK1 in controlling noncanonical NF-κB signaling.
RESULTS

Tbk1-BKO mice aberrantly produce IgA and autoantibodies
To study the in vivo function of TBK1 in regulating humoral immune responses, we crossed mice with loxP-flanked Tbk1 alleles (Tbk1 fl/fl ) with mice expressing Cre recombinase from the B cell-specific gene Cd19 (Cd19-Cre) to generate Tbk1 fl/fl mice heterozygous for the Cd19-Cre transgene (Tbk1-BKO mice) and Tbk1 +/+ mice heterozygous for the Cd19-Cre transgene (wild-type control mice; Supplementary  Fig. 1 ). Unlike mice with global TBK1 deficiency (Tbk1 −/− mice), the Tbk1-BKO mice were born at the expected Mendelian ratios and were grossly normal in growth and survival. The B cell-specific ablation of Tbk1 also did not affect the development or maturation of B cells, as suggested by the presence of similar B cell subpopulations in the spleen (Supplementary Fig. 2 ) and bone marrow (data not shown) of Tbk1-BKO and wild-type mice.
To investigate the in vivo role of TBK1 in the activation and differentiation of B cells, we immunized wild-type and Tbk1-BKO mice with the hapten NP (4-hydroxy-3-nitrophenylacetyl) linked to keyhole lympet hemocyanin (NP-KLH), lipopolysaccharide (NP-LPS) or the hydrophilic polysaccharide Ficoll (NP-Ficoll), which represent a T cell-dependent, T cell-independent type 1 or T cell-independent type 2 antigen, respectively. The production of antigen-specific IgM was moderately enhanced in the mutant mice, whereas the production antigen-specific IgG was not significantly altered ( Fig. 1a) . The production of individual IgG isotypes was either not significantly affected or moderately lower in Tbk1-BKO mice than in their wildtype counterparts ( Fig. 1b) . Notably, Tbk1-BKO mice produced much more antigen-specific IgA than did wild-type mice ( Fig. 1a) .
Under unimmunized conditions, Tbk1-BKO and age-matched wild-type control mice had similar serum concentrations of IgM and IgG throughout the time of analysis ( Fig. 1c) . At a young age (3-9 weeks), Tbk1-BKO mice also did not show obvious abnormalities in their steady-state abundance of serum IgA; however, starting from 12 weeks of age, these mutant mice had significantly higher serum IgA concentrations than those of the age-matched wild-type control mice ( Fig. 1c) . Older Tbk1-BKO mice (8 months of age) also had higher serum titers of the autoantibody antinuclear antigen and autoantibody to double-stranded DNA (Fig. 1d) , as well as prominent deposition of antibodies in the kidney glomeruli ( Fig. 1e) , a chief pathological feature of nephropathy 32 . These older mutant mice also had additional signs of nephropathy, including higher concentrations of urinary protein and serum nitrogen and creatinine ( Fig. 1f) . Thus, TBK1 expression in B cells was critical for maintaining normal production of IgA and preventing nephropathy-like disorders.
TBK1 inhibits CD40-and BAFF-induced IgA class switching
The aberrant production of IgA by the Tbk1-BKO mice prompted us to investigate the role of TBK1 in regulating IgA class switching. Consistent with their higher concentration of serum IgA, older Tbk1-BKO mice had a much greater frequency of IgA + B cells in mesenteric lymph nodes and Peyer's patches ( Fig. 2a) , lymphoid organs known to be active in IgA class switching 12 , than did age-matched wild-type npg mice. After immunization with a T cell-dependent antigen, young Tbk1-BKO mice also had a significantly greater frequency and number of IgA + B cells in the spleen than did age-matched wild-type mice (Fig. 2b) . In contrast, the frequency of IgM + and IgG1 + B cells was either not influenced or was actually lower in Tbk1-BKO mice. Studies involving adoptive transfer of B cells showed that Tbk1-BKO B cells produced substantially more IgA + B cells than did wild-type B cells in both single-transfer and mixed-transfer experiments ( Supplementary  Fig. 3) . These findings emphasized a B cell-intrinsic role for TBK1 in regulating IgA + B cell production.
We further investigated the role of TBK1 in regulating class switching to IgA with a well-characterized in vitro protocol based on the induction of such class switching by TGF-β and the TNF family members CD40L, BAFF and APRIL 11 . Notably, TBK1 deficiency did not substantially alter TGF-β-stimulated switching to IgA but greatly promoted the induction of IgA + B cells ( Fig. 2c,d ) and secreted IgA (Fig. 2d ) induced by antibody to CD40 (anti-CD40) and BAFF. We obtained similar results when we used the agonistic antibody IgM, instead of LPS, as B cell activator for the class switching to IgA (data not shown). To compare the role of TBK1 in regulating class switching to IgA and other immunoglobulin isotypes, we used a modified protocol that involved the replacement of TGF-β and APRIL with interleukin 4 (IL-4), which is known to stimulate class switching to both IgA and other isotypes such as IgG1 (refs. 9,33). As noted for the TGF-β classswitching condition, TBK1 deficiency resulted in aberrant induction of IgA + B cells by anti-CD40 and BAFF ( Supplementary Fig. 4a,b) .
Although the TBK1 deficiency also promoted BAFF-induced production of IgG1, this effect was much weaker than that on the induction of IgA ( Supplementary Fig. 4a,b) . Thus, TBK1 had a predominant role in controlling class switching to IgA.
Immunoglobulin class switching is initiated by the expression of germline transcripts (GLTs) and requires the cytidine deaminase AID 34, 35 . We found that TBK1 deficiency promoted induction of the genes encoding α-GLT and AID by anti-CD40 and BAFF, although we noted the effect on the induction of α-GLT mainly with BAFF stimulation ( Fig. 2e ). This effect of BAFF was not limited to the TGF-β class-switching condition, as we obtained similar results for the IL-4 class-switching condition (Supplementary Fig. 4c ). In contrast, TBK1 deficiency did not substantially enhance induction of the γ1 GLT ( Supplementary Fig. 4c ). Collectively, these results suggested a critical role for TBK1 in negatively regulating class switching to IgA and thus explained the aberrant IgA production in Tbk1-BKO mice.
TBK1 regulates IgA production independently of type I interferon TBK1 and IKKε are structurally related kinases that mediate the induction of type I interferon in antiviral innate immunity 36, 37 . We found that LPS-stimulated phosphorylation of the transcription factor IRF3 and expression of type I interferon was inhibited in Tbk1-BKO B cells ( Fig. 3a,b) . However, the IgA-regulating function of TBK1 was independent of the autocrine action of type I interferons, as ablation of the receptor for type I interferon in Tbk1-BKO mice did not correct the IgA-hyperproduction phenotype (Fig. 3c) . Consistent with that, B cells derived from Tbk1-BKO mice also deficient in the receptor for type I interferon remained hypersensitive to anti-CD40 and BAFF in their production of IgA + B cells ( Fig. 3d ) and expression of mRNA encoding α-GLT and AID ( Fig. 3e) . We also found that in contrast to TBK1-deficient B cells, IKKε-deficient B cells did not show any obvious abnormalities in class switching to IgA (Fig. 3f) . Thus, the TBK1mediated control of class switching to IgA was independent of type I interferon signaling and was not noted with its homolog IKKε.
TBK1 negatively regulates noncanonical NF-kB signaling
A chief signaling function of the TNF family of IgA costimulators is activation of NF-κB. Unlike LPS and antibody to the B cell antigen receptor, which induce only the canonical NF-κB pathway, BAFF and anti-CD40 are potent inducers of the noncanonical NF-κB pathway 15 . 
A r t i c l e s
In addition, although the main target of APRIL is the canonical NF-κB pathway, APRIL also weakly stimulates the noncanonical NF-κB pathway [21] [22] [23] 38, 39 . In response to the canonical NF-κB inducers LPS and anti-IgM, Tbk1-BKO B cells showed a moderate increase in NF-κB activation ( Fig. 4a and data not shown). The induction of NF-κB by APRIL was similar in wild-type and Tbk1-BKO B cells during the early phase of stimulation, although it was enhanced in the Tbk1-BKO B cells during the late phase of stimulation ( Fig. 4b) .
Notably, TBK1 deficiency greatly enhanced the activation of NF-κB induced by anti-CD40 and BAFF ( Fig. 4c,d) . These findings were in agreement with the substantial effect of TBK1 deficiency on the induction of IgA by anti-CD40 and BAFF.
In vitro kinase assays showed that loss of TBK1 only weakly promoted the activation of IKK by LPS and did not affect the anti-CD40stimulated activation of IKK ( Supplementary Fig. 5a ). As anti-CD40 and BAFF stimulate the noncanonical NF-κB pathway 15 , we reasoned that TBK1 might have a major role in regulating this specific NF-κB pathway. Indeed, the activation of nuclear p52 and RelB by anti-CD40 and BAFF was much greater in Tbk1-BKO B cells than in wild-type B cells ( Fig. 4e,f) . That result was associated with more loss of the p52 precursor p100 in the cytoplasm of Tbk1-BKO B cells than in that of wild-type B cells ( Fig. 4e,f) , which suggested a role for TBK1 in negatively regulating the induction of p100 processing. This function of TBK1 was not due to an alteration in surface receptor expression, as the Tbk1-BKO and wild-type B cells expressed similar amounts of CD40, BAFFR and TACI (data not shown). Furthermore, TBK1 deficiency did not promote activation of the NF-κB proteins p50 or c-Rel and only moderately enhanced the activation of RelA ( Supplementary  Fig. 5b) . The moderate enhancement in RelA activation in the Tbk1-BKO cells was consistent with the contribution of p100 processing to RelA activation 16 . Together these results established TBK1 as a pivotal negative regulator of the noncanonical NF-κB signaling pathway.
Noncanonical NF-kB pathway regulates IgA class switching Published studies have suggested a role for the noncanonical NF-κB pathway in regulating IgA production 6, 16, 17, 25 , although direct evidence for its involvement in class switching to IgA has been lacking. To address this question, we studied NIK-deficient mice, which are defective in noncanonical NF-κB signaling 15, 40 . NIK-deficient B cells had mostly normal TGF-β-induced class switching to IgA; however, they were defective in the induction of class switching to IgA by anti-CD40 and BAFF, as assessed by the frequency of IgA + B cells (Fig. 5a,b) . We also studied mutant mice with the Lym1 mutation npg of the gene encoding p52 (Nfkb2), which results in the production of a nonprocessible form of p100 and, thus, the blockade of noncanonical NF-κB activation 16 . Both homozygous Nfkb2 Lym1/Lym1 mice and heterozygous Nfkb2 Lym1/+ mice have severe immunological deficiencies, including attenuated IgA production 16 . We found that in response to anti-CD40 or BAFF, Nfkb2 Lym1/+ B cells had a considerable defect in the production of IgA + B cells (Fig. 5c) . In the IL-4-based class-switching condition, we found that NIK deficiency or the Lym1 mutation of Nfkb2 resulted in only slightly less anti-CD40-or BAFF-mediated induction of IgG1 + B cells, whereas these genetic changes considerably inhibited the induction of IgA + B cells (Supplementary Fig. 6a ). Consistent with that, NIK deficiency or the Lym1 mutation of Nfkb2 substantially attenuated anti-CD40-or BAFF-induced expression of α-GLT but only had a weak or no effect on the induction of γ1 GLT (Supplementary Fig. 6a ). These results further suggested that the noncanonical NF-κB had a predominant role in promoting class switching to IgA, although it may have also been involved in the induction of other antibody isotypes.
We next investigated the involvement of the noncanonical NF-κB pathway in mediating IgA hyperproduction in TBK1-deficient B cells by crossing Tbk1-BKO mice with NIK-deficient mice. Although TBK1 deficiency in NIK-sufficient mice resulted in a much more antigen-induced production of IgA + B cells, loss of TBK1 on the NIKdeficient background did not appreciably promote the production of IgA + B cells ( Fig. 5d and Supplementary Fig. 6b ). Furthermore, B cell-specific ablation of Tbk1 on the NIK-deficient background also did not cause an abnormally higher titer of antigen-specific serum IgA (Supplementary Fig. 6c) . Thus, the noncanonical NF-κB pathway seemed to be responsible for the IgA hyperproduction in Tbk1-BKO mice.
To rule out the possible involvement of B cell development in the IgA class-switching defect of the NIK-deficient B cells, we knocked down NIK in wild-type and Tbk1-BKO B cells through the use of a lentiviral vector expressing Map3k14-specific short hairpin RNA as well as green fluorescent protein (GFP); the latter allows enrichment for infected cells through sorting by flow cytometry. This knockdown of NIK not only attenuated the induction of IgA + B cells among wild-type B cells but also abrogated the hyperinduction of IgA + B cells among Tbk1-BKO B cells (Fig. 5e) . We obtained similar results with a different Map3k14-specific short hairpin RNA (data not shown). We also examined the effect of the knockdown of NIK on B cell proliferation. Tbk1-BKO B cells had enhanced proliferative ability relative to that of wild-type B cells in response to stimulation with anti-CD40 or BAFF, as well as in response to LPS or anti-IgM ( Supplementary  Fig. 7) . Notably, the hyperproliferative phenotype of Tbk1-BKO B cells, stimulated by either noncanonical or canonical inducers of NF-κB, was dependent on NIK (Supplementary Fig. 7) . One possibility for these results was that B cells isolated from Tbk1-BKO mice had already accumulated small amounts of NIK because of in vivo exposure to inducers (such as BAFF). Collectively, these data suggested a critical role for NIK and its downstream noncanonical NF-κB pathway in mediating the IgA hyperproduction of TBK1-deficient B cells.
TBK1 is a negative regulator of NIK Although TBK1 has been linked to antiviral innate immune responses, published work has suggested activation of this kinase by additional inducers 41, 42 . Notably, we found that both APRIL and BAFF potently stimulated activation of TBK1 (Fig. 6a) . As BAFF stimulates both BAFFR and TACI in B cells, we assessed the contribution of these receptors to the phosphorylation of TBK1 through the use of NIH3T3 mouse fibroblasts stably transduced to express TACI or BAFFR. BAFF and APRIL stimulated strong activation of TBK1 in TACI-expressing NIH3T3 cells and weak activation of TBK1 in BAFFR-expressing NIH3T3 cells (Fig. 6b) . Those results suggested that TACI may be the main receptor that mediates BAFF-stimulated activation of TBK1, although the relative expression of TACI and BAFFR may also be an influencing factor. Parallel experiments showed that anti-CD40, as well as LPS and anti-IgM, also stimulated the phosphorylation of TBK1 (Fig. 6c) .
A central signaling mechanism of the noncanonical NF-κB pathway is control of the fate of NIK 15 . Under steady-state conditions, NIK undergoes basal degradation via its ubiquitination by a TRAF3-dependent ubiquitin ligase complex composed of TRAF2 and c-IAP, and induction of p100 processing involves TRAF3 degradation A r t i c l e s and NIK accumulation 15 . Notably, we found that TBK1 deficiency promoted the induction of NIK by both anti-CD40 and BAFF (Fig. 6d) . The greater abundance of NIK protein in Tbk1-BKO cells was not due to higher Map3k14 expression (data not shown) and did not seem to involve upstream signaling events, as TBK1 deficiency had no obvious effect on the degradation of TRAF3 (Fig. 6d) or the abundance of TRAF2, c-IAP2 or IKKα protein (data not shown).
To assess whether TBK1 is directly involved in NIK regulation, we investigated whether TBK1 physically interacted with NIK in wild-type B cells. As the steady-state abundance of NIK is too low for detection, we incubated the cells with the proteasome inhibitor MG132 to allow NIK to accumulate. In the absence of a stimulus, there was little coimmunoprecipitation of TBK1 with NIK; however, after stimulation of the cells with anti-CD40 or BAFF, TBK1 formed a stable complex with NIK ( Fig. 6e) . Notably, IKKε was not recruited to NIK, despite its abundant expression in these cells (Fig. 6e) . We further confirmed the NIK-TBK1 physical interaction with a transfection model, which demonstrated that TBK1 interacted with NIK, but IKKε did not (Fig. 6f) . These findings suggested a direct mechanism by which TBK1 controls the fate of NIK.
TBK1 induces NIK phosphorylation and degradation
To further examine the mechanism by which TBK1 regulates NIK, we investigated whether TBK1 induced the degradation of NIK in transfected cells. Indeed, when NIK was expressed together with TBK1, the abundance of NIK, but not that of the internal control protein GFP, was much lower than when NIK was expressed alone (Fig. 7a) . We did not obtain that result with a 'kinase-dead' TBK1 mutant, and the effect was blocked by the proteasome inhibitor MG132 (Fig. 7a) , which suggested that TBK1 might mediate phosphorylation-dependent degradation of NIK. Indeed, extension of the protein-fractionation time in SDS gels identified TBK1-induced NIK that migrated more slowly, which probably represented phosphorylated NIK (Fig. 7b) . Notably, the TBK1 homolog IKKε did not induce degradation of NIK (Fig. 7b) . Consistent with the published finding that IKKα phosphorylates NIK 43 , IKKα and a constitutively active mutant of IKKα each promoted generation of NIK that migrated more slowly (Fig. 7b) . Notably, however, IKKα was insufficient for inducing NIK degradation 43 (Fig. 7b) . By generating a panel of NIK mutants, we found that deletion of 100 amino acids from the carboxyl terminus of NIK generated a mutant (containing amino acids 1-847) that was resistant to TBK1-induced degradation, but truncation of NIK from the amino terminus up to amino acid 238 did not affect TBK1-induced degradation of NIK (Fig. 7c) . This result suggested that the degradationregulatory sequence of NIK might be located in its carboxy-terminal region. As two of the amino-terminal truncation mutants (containing amino acids 152-947 and 238-947) lacked the TRAF3-binding site 44 , this finding also ruled out the possibility of the involvement of TRAF3 in TBK1-stimulated degradation of NIK.
To directly determine whether TBK1 mediated NIK phosphorylation, we purified NIK from mouse cells transfected to express either NIK alone or NIK plus TBK1 and then used mass spectrometry to identify the phosphorylation sites of NIK. TBK1 stimulated phosphorylation of NIK at several serine residues ( Supplementary  Table 1 ). Most notable was Ser862, which is conserved in human and mouse NIK and is located in the degradation-determination region (amino acids 847-947) identified in the truncation studies (Fig. 7c) . Substitution of the serine at this site with alanine generated a NIK point mutant (S862A) that became resistant to TBK1induced degradation, whereas substitution of several other potential phosphorylation sites of NIK did not affect its degradation (Fig. 7d) . Notably, TBK1 did not phosphorylate Ser809, Ser812 or Ser815 of NIK (Supplementary Table 1) , which have been shown to be phosphorylated by IKKα and to regulate the steady-state abundance 43 . Substitution of those serine residues also did not affect TBK1-induced degradation of NIK (Fig. 7d) .
To examine the role of Ser862 in signal-induced degradation of NIK, we stably expressed wild-type NIK or NIK(S862A) in mouse M12.4.1 (M12) B cells. NIK(S862A) did not show enhanced stability at steady state (Fig. 7e) . However, in response to either anti-CD40 or BAFF, there was much more accumulation of NIK(S862A) than of wild-type NIK (Fig. 7e) . These findings further emphasized a role for TBK1-induced phosphorylation of NIK in mediating the degradation of NIK.
To examine the functional importance of TBK1-induced degradation of NIK in class switching to IgA, we reconstituted NIK-deficient B cells with wild-type NIK or NIK(S862A). Reconstitution of the cells with wild-type NIK greatly promoted the induction of IgA + cells (Fig. 7f,g) . Probably because of its constitutive activity, wild-type NIK also promoted the induction of IgA in the absence of anti-CD40 or BAFF. More notably, expression of NIK(S862A) resulted in an even higher frequency of IgA + B cells (Fig. 7f,g) . Together these findings suggested that TBK1-mediated phosphorylation and degradation of NIK served as a negative mechanism to prevent aberrant noncanonical activation of NF-κB and class switching to IgA.
DISCUSSION
The data presented in this study have demonstrated a unique and unexpected role for TBK1 in controlling the production of IgA. B cell-specific TBK1 deficiency not only caused aberrant induction of IgA by antigens but also led to higher steady-state concentrations of serum IgA and the development of nephropathy-like signs in older mice. Although the induction of class switching to IgA involves several signals, TBK1 specifically regulates the costimulatory signaling induced by BAFF, anti-CD40 and, to a lesser extent, APRIL. We obtained genetic evidence that TBK1 negatively regulated the noncanonical NF-κB pathway by controlling the fate of NIK in B cells stimulated by anti-CD40 or BAFF. Published studies have suggested that the steady-state amount of NIK is regulated by a TRAF3-dependent ubiquitin ligase composed of c-IAP1 and TRAF2 (ref. 15 ). IKKα also mediates the phosphorylation and stability of NIK, although the role of the latter finding in vivo remains unclear 43 . We found that in contrast to those known regulators of NIK, TBK1 regulated the fate of NIK mainly under inducible conditions.
Our data have shown that the TBK1 deficiency had no effect on TRAF3 degradation, which suggests that the TBK1-mediated NIK regulation does not involve upstream signaling steps. Indeed, TBK1 physically associated with NIK in a signal-dependent manner and stimulated the phosphorylation and degradation of NIK. This function of NIK seemed to be highly specific, as the TBK1 homolog IKKε did not bind NIK or induce NIK degradation. Consistent with that, IKKε was also dispensable for the control of class switching to IgA. Published studies have suggested that TBK1 and IKKε also inhibit activation of the canonical IKK 42, 45 . However, TBK1 and IKKε may be functionally redundant in mediating this function, as TBK1 deficiency in B cells had only a weak stimulatory effect on LPS-stimulated activation of IKK. It is also possible that the role of TBK1 in regulating canonical activation of IKK is cell type specific. Nevertheless, our work has demonstrated a nonredundant role for TBK1 in the regulation of NIK and the noncanonical NF-κB pathway.
The noncanonical NF-κB pathway is traditionally thought to mediate the nuclear translocation of only the RelB-p52 dimer. However, theoretically, the noncanonical NF-κB pathway should regulate any NF-κB member that is sequestered by p100. In fact, it has been shown A r t i c l e s that a large proportion of cytoplasmic RelA is sequestered by p100 (ref. 46) . Although the activation of RelA by many inducers, including TNF and IL-1, does not require NIK or processing of p100, the activation of RelA by noncanonical NF-κB inducers, such as anti-CD40, is partially dependent on NIK and p100 processing 16 . Thus, the function of the noncanonical NF-κB pathway is beyond what has been learned from the study of RelB-deficient mice and p52-deficient mice. Through the use of Nfkb2 Lym1/+ and NIK-deficient B cells, we have shown that the noncanonical NF-κB pathway has a crucial role in regulating class switching to IgA, which explains the impaired IgA production in Nfkb2 Lym1/+ and NIK-mutant mice 16, 17 and the IgA hyperproduction in mice with transgenic expression of BAFF 5,6 . Our findings have also provided insight into the molecular mechanism by which members of the TNF family promote class switching to IgA.
TBK1 is best known as a kinase that responds to adaptor TRIFdependent Toll-like receptors and intracellular sensors of nucleic acid [26] [27] [28] [29] [30] . However, studies have suggested that TBK1 responds to previously unappreciated signals, such as those triggered by the adaptor MyD88-dependent Toll-like receptors and TNF 42 . Our study has further demonstrated the activation of TBK1 by signals elicited via CD40, TACI and BAFFR, as well as the B cell antigen receptor. BAFFR seemed to be a much weaker stimulator of TBK1 than was TACI. However, as BAFF stimulates both BAFFR and TACI on B cells, it is likely that the TACI-mediated activation of TBK1 provides a negative signal for BAFFR-mediated induction of noncanonical NF-κB signaling.
In summary, our findings have provided insight into the mechanism of noncanonical NF-κB regulation and have established TBK1 as a pivotal regulator of this signaling pathway. Our work has also demonstrated a role for TBK1 and the noncanonical NF-κB pathway in the regulation of class switching to IgA. Given the involvement of the noncanonical NF-κB pathway in various biological processes, our findings have implications for the development of new therapeutic approaches.
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